Andy is a Partner at HGF with around 15 years’ experience.
He is a UK and European Patent Attorney and specialises in the fields of chemistry and pharmaceuticals.
Over the years, Andy has worked with many start-ups and SMEs, having secured patent protection for their innovations. He has experience of providing support during investment rounds by interacting with investors. As well as SMEs and start-ups, Andy also works closely with the Technology Transfer and Commercialisation Teams in the University of Leeds, the University of Hull and Bradford University acting as their primary point of contact at HGF.
His day-to-day practice involves providing advice and support in identifying and capturing commercially useful patentable subject matter, providing easy-to-digest guidance for how to obtain granted patents in countries around the world, advising on how third party rights might affect commercial decisions and what can be done to mitigate any risks posed by third party rights.
MSci in Chemistry
September 24th 2020
March 6th 2019
March 6th 2019
March 7th 2018
January 23rd 2018
Andy is the relationship manager for Nexus in Leeds. Nexus is the Incubation Hub situated on the University of Leeds campus. This involves providing seminars and workshops to the tenants at Nexus and in the wider Leeds City Region, offering drop-in sessions to discuss Nexus’ tenants IP strategy and being on hand to provide guidance to the tenants on various IP issues, which is a complex and confusing area of law.
Andy has also run a summer internship programme for undergraduates at the University of Nottingham in both the chemistry team and the engineering team at HGF.
The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’. Such a refusal can …Read article
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.